cas 1419101-40-8|| where to buy Methyl 6,6-difluorospiro[3.3]heptane-2-carboxylate

Nom du produit:Methyl 6,6-difluorospiro[3.3]heptane-2-carboxylate

IUPAC Name:methyl 6,6-difluorospiro[3.3]heptane-2-carboxylate

Unité d'emballage	Stock disponible	Prix($)
CM209093-100mg	in stock	ǊƦɅ
CM209093-250mg	in stock	ǊɅǧ
CM209093-1g	in stock	Ȭȁȁ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 1419101-40-8 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:1419101-40-8; Formule moléculaire:C9H12F2O2; Point de fusion:-; Code SMILES:O=C(C1CC2(CC(F)(F)C2)C1)OC; Densité:

: Numéro de catalogue:CM209093; Poids moléculaire:190.19; Point d'ébullition:; N° Mdl:MFCD23106457; Stockage:

: Fluorinated Compounds; Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.

: Cyclobutanes; The molecular structure of cyclobutane has four carbon atoms, and its four carbon atoms are not in the same plane, which is the folded conformation of cyclobutane. Cyclobutane itself is not of commercial or biological interest, but more complex derivatives are important in biology and biotechnology. Currently, nine FDA-approved drugs contain the cyclobutane structure. From the perspective of therapeutic areas, cyclobutyl drugs are mainly distributed in popular areas such as tumors, neurological diseases, infectious diseases, endocrine and metabolic diseases.

: Fluorinated compounds; Fluorinated compounds refers to organic or inorganic compounds containing fluorine.